Wellington Management Group
ABEO icon

Wellington Management Group’s Abeona Therapeutics ABEO Stock Holding History

Wellington Management Group’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-150,929
Closed -$797K – 1914
2025
Q3 		$797K Sell
150,929
-23,585
-14% -$150K ﹤0.01% 1817
2025
Q2 		$991K Buy
174,514
+21,393
+14% +$122K ﹤0.01% 1723
2025
Q1 		$729K Buy
153,121
+59,832
+64% +$325K ﹤0.01% 1769
2024
Q4 		$520K Buy
+93,289
New +$574K ﹤0.01% 1826
2021
Q1 		– Sell
-38,709
Closed -$1.52M – 2082
2020
Q4 		$1.52M Sell
38,709
-109,520
-74% -$3.73M ﹤0.01% 1538
2020
Q3 		$3.78M Sell
148,229
-32,616
-18% -$2.06M ﹤0.01% 1313
2020
Q2 		$13.2M Sell
180,845
-36,895
-17% -$2.55M ﹤0.01% 1014
2020
Q1 		$11.4M Sell
217,740
-41,026
-16% -$2.74M ﹤0.01% 1008
2019
Q4 		$21.2M Buy
258,766
+92,197
+55% +$6.51M ﹤0.01% 968
2019
Q3 		$9.41M Buy
166,569
+19,230
+13% +$1.44M ﹤0.01% 1182
2019
Q2 		$17.6M Sell
147,339
-21,328
-13% -$3.58M ﹤0.01% 1041
2019
Q1 		$31M Buy
168,667
+5,833
+4% +$1.04M 0.01% 886
2018
Q4 		$29.1M Buy
162,834
+31,349
+24% +$6.84M 0.01% 884
2018
Q3 		$42.1M Buy
131,485
+30,969
+31% +$11M 0.01% 857
2018
Q2 		$40.2M Buy
100,516
+15,930
+19% +$6.96M 0.01% 866
2018
Q1 		$30.3M Buy
84,586
+24,689
+41% +$9.17M 0.01% 932
2017
Q4 		$23.7M Buy
59,897
+51,598
+622% +$21.3M 0.01% 1019
2017
Q3 		$3.54M Buy
8,299
+686
+9% +$184K ﹤0.01% 1575
2017
Q2 		$1.22M Sell
7,613
-571
-7% -$77.9K ﹤0.01% 1835
2017
Q1 		$1.02M Buy
8,184
+1,212
+17% +$156K ﹤0.01% 1917
2016
Q4 		$845K Buy
+6,972
New +$1.09M ﹤0.01% 1902

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Wellington Management Group's ABEO Position: Q4 2025 in Review

Wellington Management Group sold out of Abeona Therapeutics (ABEO) in Q4 2025, closing a stake of 150,929 shares — an estimated $797K sold.

Wellington Management Group first reported a position in ABEO in Q4 2016 and held it in 21 quarters. The position peaked at $42.1M in Q3 2018. 104 funds tracked by Wall St. Rank hold ABEO as of Q4 2025.

  • Wellington Management Group reported no remaining Abeona Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Wellington Management Group sold 150,929 Abeona Therapeutics shares in Q4 2025, an estimated $797K.
  • Wellington Management Group first reported a position in Abeona Therapeutics in Q4 2016 and held it in 21 quarters.
  • Wellington Management Group's Abeona Therapeutics position peaked at $42.1M in Q3 2018.
  • 104 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2025.

Based on Wellington Management Group's 13F filing for Q4 2025, filed 17 Feb 2026.